STOCK TITAN

[144] Royalty Pharma plc SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RPRX submitted a Form 144 reporting a proposed sale of 100,462 shares of Common Stock acquired on 06/20/2020.

The filing lists the broker Goldman Sachs & Co. LLC and records multiple sales by affiliated entities over the prior three months, including transactions dated 01/07/2026, 01/21/2026, and 03/04/2026 with share amounts and gross proceeds documented in the filing.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the market of an intended resale of restricted or control stock.

The filing identifies 100,462 shares of Common Stock acquired 06/20/2020 and lists Goldman Sachs & Co. LLC as the broker. That quantity is presented as the securities to be sold in this notice.

Recent executed transactions by affiliated holders are enumerated with dates and gross proceeds, which investors can use as a trading history reference; subsequent filings will report completed dispositions.

The filing shows active resale activity by related entities over the past three months.

The excerpt records multiple sales: for example, GWL 2013 NG LLC sold 123,965 shares on 01/07/2026 and 123,965 shares on 01/21/2026, with gross proceeds listed. Another entry shows George Lloyd IRA sold 136,980 shares on 03/04/2026 for a stated dollar amount.

These executed sales provide context for the Form 144 notice; the filing itself documents intent to resell 100,462 shares acquired in 2020.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RPRX's Form 144 report?

The Form 144 reports a proposed resale of 100,462 shares of Common Stock acquired on 06/20/2020. It lists the broker Goldman Sachs & Co. LLC and documents prior sales by affiliated holders.

Who appears as broker for the RPRX sale in the Form 144?

The filing names Goldman Sachs & Co. LLC at 200 West Street, New York. That broker is associated with the sale notice and is shown on the securities information line.

Does the excerpt show prior resale activity for RPRX shares?

Yes. The filing lists multiple recent sales, including 123,965 shares on 01/07/2026 and 136,980 shares on 03/04/2026, each with stated gross proceeds in dollars.

When were the securities to be sold originally acquired?

The securities identified for resale—100,462 shares—were acquired from the issuer in a private transaction on 06/20/2020, as shown in the filing.
Royalty Pharma Plc

NASDAQ:RPRX

View RPRX Stock Overview

RPRX Rankings

RPRX Latest News

RPRX Latest SEC Filings

RPRX Stock Data

19.51B
396.11M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK